Proteomics: Biomedical and Pharmaceutical Applications
DOI: 10.1007/1-4020-2323-5_3
|View full text |Cite
|
Sign up to set email alerts
|

Proteomics: Haematological Perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 196 publications
0
2
0
Order By: Relevance
“…Removal of fibrinogen (Factor I) is easily obtained by clotting. However, this method induced the disappearance of many other proteins involved in the coagulation process such as prothrombin (Factor II), which is absent in serum [21]. Inversely, many peptides, absent in plasma but detectable in serum, can be identified after coagulation.…”
Section: Overviewmentioning
confidence: 99%
See 1 more Smart Citation
“…Removal of fibrinogen (Factor I) is easily obtained by clotting. However, this method induced the disappearance of many other proteins involved in the coagulation process such as prothrombin (Factor II), which is absent in serum [21]. Inversely, many peptides, absent in plasma but detectable in serum, can be identified after coagulation.…”
Section: Overviewmentioning
confidence: 99%
“…B lymphocytes eventually differentiate into plasma cells and secrete antibodies, which corresponds to the humoral immune response, whereas T lymphocytes play a determinant role in the cellular immune response. Several studies report on the proteome of T cells [21]. T lymphocytes can be divided into two main classes.…”
Section: Leukocytesmentioning
confidence: 99%